MEDRANO GUZMAN, RAFAEL
INVESTIGACIÓN MÉDICA · Nivel 1
Desde 2020 es DIRECTOR GENERAL UMAE ONCOLOGÍA en Instituto Mexicano del Seguro Social
Información*
| Nombre | RAFAEL MEDRANO GUZMAN |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | INVESTIGACIÓN MÉDICA |
| Disciplina | CIRUGÍA ONCOLÓGICA |
| Especialidad | ONCOLOGIA, QUIMIOTERAPIA, CIRUGIA ONCOLOGIA |
| CVU | 511280 |
| Institución | |
|---|---|
| Dependencia | OOAD CDMX SUR |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2024 |
| Fin: 31/12/2028 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Últimas publicaciones Scopus
- 2026
- Factors Associated with Complete Clinical Response After Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Mexican Retrospective Study World Journal of Gastrointestinal Oncology · Vol. 18 Article
- 2025
- Systematic review and epistemic meta-analysis to advance binomial AI-radiomics integration for predicting high-grade glioma progression and enhancing patient management Scientific Reports · Vol. 15 Article
- 2024
- Focal-to-bilateral tonic-clonic seizures and High-grade CMV-infection are poor survival predictors in Tumor-related Epilepsy Adult-type diffuse gliomas—A single-center study and literature review Heliyon · Vol. 10 Article
- 2023
- Extremity soft tissue sarcoma: does surgical margin impact survival? Cirugia Y Cirujanos · Vol. 9 Article
- PSEUDOPROGRESSION AND HYPERPROGRESSION SECONDARY TO IMMUNOTHERAPY IN LUNG CANCER World Cancer Research Journal · Vol. 10 Review